Simultaneous occurrence of Hodgkin's lymphoma and multiple myeloma: A case report and review of the literature.

Hodgkin's lymphoma (HL) is a type of hematological neoplasm that generally appears alone, with a low incidence. The majority of cases histopathologically present as B-cell lymphoma. Multiple myeloma (MM) is defined as the neoplastic proliferation of a single clone of plasma cells producing a monoclonal immunoglobulin (Ig). The coexistence of HL and MM is rare, however, the present study reports such a case. On May 31, 2012, a 45-year-old man was diagnosed with HL, stage III, 31 months ago. At the same time, computed tomography and magnetic resonance imaging showed osteolytic lesions, a significant increase in IgA λ chains, and multiple myeloma cells on bone marrow aspiration. Following 8 cycles of chemotherapy, the patient received maintenance treatment with thalidomide and dexamethasone. During 2 years of follow-up, the patient has maintained a complete response for HL and a stable disease state for MM. The coexistence of HL and MM is rare. Further study of such cases may explain the associations between these two tumors and aid the production of effective treatment options.

[1]  A. Athanasiadou,et al.  Simultaneous occurrence of multiple myeloma and Hodgkin's disease. A case report. , 2000, Haematologica.

[2]  P. Revell,et al.  The simultaneous presentation of Hodgkin's disease of myeloma. , 1977, Postgraduate medical journal.

[3]  E. Jaffe,et al.  The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  M. Sunday Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus. , 1981, The New England journal of medicine.

[5]  S. Glaser,et al.  Hodgkin's disease in Asians: incidence patterns and risk factors in population-based data. , 2002, Leukemia research.

[6]  M. Raffeld,et al.  Rearranged antigen receptor genes in Hodgkin's disease [published erratum appears in Blood 1987 Sep;70(3):893] , 1987 .

[7]  M. Martínez-González,et al.  Simultaneous occurrence of Hodgkin’s disease, nodal Langerhans’ cell histiocytosis and multiple myeloma IgA(κ) , 1999, Virchows Archiv.

[8]  S. Pileri,et al.  The EnVision TM + system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, , 1998 .

[9]  B. Klein,et al.  Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-IL-6 treatments. , 1995, Blood.

[10]  P. Schröttner,et al.  Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma , 2011, Leukemia & lymphoma.

[11]  M. Griem,et al.  Mycosis fungoides and Hodgkin's disease occurring in the same patient. Report of three cases , 1979, Cancer.

[12]  M. Raffeld,et al.  Rearranged antigen receptor genes in Hodgkin's disease. , 1987, Blood.

[13]  N. Harris,et al.  The relationship between Hodgkin's disease and non-Hodgkin's lymphoma. , 1992, Seminars in diagnostic pathology.

[14]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[15]  R. Kurzrock,et al.  Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease. , 1997, The American journal of medicine.

[16]  R. Advani,et al.  Customized targeted therapy in Hodgkin lymphoma: hype or hope? , 2014, Hematology/oncology clinics of North America.

[17]  K. Rajewsky,et al.  Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. , 1999, The New England journal of medicine.

[18]  H. Tilly,et al.  Cytogenetic studies in untreated Hodgkin's disease. , 1991, Blood.

[19]  P. Tosi Diagnosis and Treatment of Bone Disease in Multiple Myeloma: Spotlight on Spinal Involvement , 2013, Scientifica.

[20]  M. Brigden Treatment of early-stage Hodgkin's disease. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[21]  D. Linch,et al.  Hodgkin's lymphoma in adults , 2012, The Lancet.

[22]  J. Vardiman,et al.  Hodgkin's disease associated with chronic lymphocytic leukemia. Eight additional cases, including two of the nodular lymphocyte predominant type. , 1995, American journal of clinical pathology.

[23]  D. Stats,et al.  The simultaneous occurrence of plasma cell multiple myeloma and Hodgkin's disease. , 1950, New York state journal of medicine.

[24]  M. Kersten,et al.  Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  S. Salmon,et al.  A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival , 1975, Cancer.

[26]  Huan Xu,et al.  Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution , 2011, Diagnostic pathology.

[27]  D. Smithers Summary of papers delivered at the Conference on Staging in Hodgkin's Disease (Ann Arbor). , 1971, Cancer research.